S&P 500   5,251.80 (+0.06%)
DOW   39,789.67 (+0.07%)
QQQ   444.19 (-0.14%)
AAPL   171.55 (-1.02%)
MSFT   419.42 (-0.48%)
META   487.45 (-1.30%)
GOOGL   150.88 (+0.01%)
AMZN   179.71 (-0.07%)
TSLA   178.57 (-0.70%)
NVDA   892.52 (-1.11%)
NIO   4.69 (+0.43%)
AMD   179.45 (-0.08%)
BABA   72.16 (+0.80%)
T   17.64 (+0.51%)
F   13.16 (+0.77%)
MU   119.05 (-0.08%)
CGC   9.07 (-5.03%)
GE   177.49 (-1.46%)
DIS   121.30 (+0.26%)
AMC   3.80 (-12.44%)
PFE   27.82 (+0.14%)
PYPL   66.81 (+0.36%)
XOM   115.75 (+0.68%)
S&P 500   5,251.80 (+0.06%)
DOW   39,789.67 (+0.07%)
QQQ   444.19 (-0.14%)
AAPL   171.55 (-1.02%)
MSFT   419.42 (-0.48%)
META   487.45 (-1.30%)
GOOGL   150.88 (+0.01%)
AMZN   179.71 (-0.07%)
TSLA   178.57 (-0.70%)
NVDA   892.52 (-1.11%)
NIO   4.69 (+0.43%)
AMD   179.45 (-0.08%)
BABA   72.16 (+0.80%)
T   17.64 (+0.51%)
F   13.16 (+0.77%)
MU   119.05 (-0.08%)
CGC   9.07 (-5.03%)
GE   177.49 (-1.46%)
DIS   121.30 (+0.26%)
AMC   3.80 (-12.44%)
PFE   27.82 (+0.14%)
PYPL   66.81 (+0.36%)
XOM   115.75 (+0.68%)
S&P 500   5,251.80 (+0.06%)
DOW   39,789.67 (+0.07%)
QQQ   444.19 (-0.14%)
AAPL   171.55 (-1.02%)
MSFT   419.42 (-0.48%)
META   487.45 (-1.30%)
GOOGL   150.88 (+0.01%)
AMZN   179.71 (-0.07%)
TSLA   178.57 (-0.70%)
NVDA   892.52 (-1.11%)
NIO   4.69 (+0.43%)
AMD   179.45 (-0.08%)
BABA   72.16 (+0.80%)
T   17.64 (+0.51%)
F   13.16 (+0.77%)
MU   119.05 (-0.08%)
CGC   9.07 (-5.03%)
GE   177.49 (-1.46%)
DIS   121.30 (+0.26%)
AMC   3.80 (-12.44%)
PFE   27.82 (+0.14%)
PYPL   66.81 (+0.36%)
XOM   115.75 (+0.68%)
S&P 500   5,251.80 (+0.06%)
DOW   39,789.67 (+0.07%)
QQQ   444.19 (-0.14%)
AAPL   171.55 (-1.02%)
MSFT   419.42 (-0.48%)
META   487.45 (-1.30%)
GOOGL   150.88 (+0.01%)
AMZN   179.71 (-0.07%)
TSLA   178.57 (-0.70%)
NVDA   892.52 (-1.11%)
NIO   4.69 (+0.43%)
AMD   179.45 (-0.08%)
BABA   72.16 (+0.80%)
T   17.64 (+0.51%)
F   13.16 (+0.77%)
MU   119.05 (-0.08%)
CGC   9.07 (-5.03%)
GE   177.49 (-1.46%)
DIS   121.30 (+0.26%)
AMC   3.80 (-12.44%)
PFE   27.82 (+0.14%)
PYPL   66.81 (+0.36%)
XOM   115.75 (+0.68%)

Teladoc Health (TDOC) Stock Price, News & Analysis

$15.32
+0.05 (+0.33%)
(As of 09:33 AM ET)
Today's Range
$15.27
$15.39
50-Day Range
$14.40
$21.61
52-Week Range
$14.29
$30.41
Volume
86,985 shs
Average Volume
4.63 million shs
Market Capitalization
$2.56 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.43

Teladoc Health MarketRank™ Stock Analysis

Analyst Rating
Hold
2.46 Rating Score
Upside/​Downside
46.9% Upside
$22.43 Price Target
Short Interest
Healthy
12.14% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.62mentions of Teladoc Health in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$2.03 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.07) to ($0.75) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.24 out of 5 stars

Medical Sector

317th out of 939 stocks

Offices & Clinics Of Medical Doctors Industry

1st out of 7 stocks

TDOC stock logo

About Teladoc Health Stock (NYSE:TDOC)

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

TDOC Stock Price History

TDOC Stock News Headlines

LifeMD Shares Come Back to Life on GLP-1 Business Growth (TDOC)
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024
A lot of people are making this costly mistake
You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
Can WeightWatchers Regain its Mojo after Oprah Steps Down? (TDOC)
WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD).
Can WeightWatchers Regain Its Mojo after Oprah Steps Down?
WW International Inc. NASDAQ: WW (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). The company made a praiseworthy strategic pivot in 2023, acquiring Sequence Inc. to enter into the GLP-1 clinical weight loss space, gaining the ability to prescribe medications like Novo Nordisk A/V NYSE: NVO owned Ozempic and Wegovy and Eli Lilly& Co. NYSE: LLY GLP-1 agonists like Mounjaro and Zepbound.
Hims & Hers Stock Rises On Stimulating Earnings Growth (TDOC)
Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audience
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
3 Disruptive Stocks Redefining Their Sectors
TDOC Mar 2024 12.000 call
TDOC Mar 2024 10.000 put
See More Headlines
Receive TDOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/20/2024
Today
3/28/2024
Next Earnings (Estimated)
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Fax
N/A
Employees
5,600
Year Founded
2002

Price Target and Rating

Average Stock Price Target
$22.43
High Stock Price Target
$29.00
Low Stock Price Target
$17.00
Potential Upside/Downside
+46.9%
Consensus Rating
Hold
Rating Score (0-4)
2.46
Research Coverage
13 Analysts

Profitability

Net Income
$-220,370,000.00
Pretax Margin
-8.44%

Debt

Sales & Book Value

Annual Sales
$2.60 billion
Cash Flow
$0.82 per share
Book Value
$14.05 per share

Miscellaneous

Free Float
164,316,000
Market Cap
$2.55 billion
Optionable
Optionable
Beta
0.94

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

TDOC Stock Analysis - Frequently Asked Questions

Should I buy or sell Teladoc Health stock right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last twelve months. There are currently 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TDOC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TDOC, but not buy additional shares or sell existing shares.
View TDOC analyst ratings
or view top-rated stocks.

What is Teladoc Health's stock price target for 2024?

13 Wall Street analysts have issued 1 year target prices for Teladoc Health's stock. Their TDOC share price targets range from $17.00 to $29.00. On average, they expect the company's share price to reach $22.43 in the next year. This suggests a possible upside of 46.9% from the stock's current price.
View analysts price targets for TDOC
or view top-rated stocks among Wall Street analysts.

How have TDOC shares performed in 2024?

Teladoc Health's stock was trading at $21.55 on January 1st, 2024. Since then, TDOC stock has decreased by 29.1% and is now trading at $15.27.
View the best growth stocks for 2024 here
.

When is Teladoc Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our TDOC earnings forecast
.

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) announced its earnings results on Tuesday, February, 20th. The health services provider reported ($0.17) EPS for the quarter, beating analysts' consensus estimates of ($0.22) by $0.05. The health services provider earned $660.50 million during the quarter, compared to analyst estimates of $670.79 million. Teladoc Health had a negative net margin of 8.47% and a negative trailing twelve-month return on equity of 9.22%. Teladoc Health's revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.23) earnings per share.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health updated its first quarter 2024 earnings guidance on Tuesday, February, 20th. The company provided earnings per share (EPS) guidance of -0.550--0.450 for the period, compared to the consensus EPS estimate of -0.430. The company issued revenue guidance of $630.0 million-$645.0 million, compared to the consensus revenue estimate of $672.9 million.

What is Jason Gorevic's approval rating as Teladoc Health's CEO?

106 employees have rated Teladoc Health Chief Executive Officer Jason Gorevic on Glassdoor.com. Jason Gorevic has an approval rating of 95% among the company's employees. This puts Jason Gorevic in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Block (SQ), Shopify (SHOP), DocuSign (DOCU), Salesforce (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

When did Teladoc Health IPO?

Teladoc Health (TDOC) raised $112 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include ARK Investment Management LLC (12.82%), Vanguard Group Inc. (10.58%), Vanguard Group Inc. (10.49%), Sumitomo Mitsui Trust Holdings Inc. (4.51%), Nikko Asset Management Americas Inc. (4.51%) and Dimensional Fund Advisors LP (2.32%). Insiders that own company stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Claus Torp Jensen, Daniel Trencher, David Travers, David William Sides, Glen Tullman, Hemant Taneja, Jason N Gorevic, Karen L Daniel, Laizer Kornwasser, Mala Murthy, Michael Willem Waters, Nikolaos P Nanis, Richard J Napolitano, Sandra L Fenwick, Stephany Verstraete and Vidya Raman-Tangella.
View institutional ownership trends
.

How do I buy shares of Teladoc Health?

Shares of TDOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Teladoc Health have any subsidiaries?
The following companies are subsidiares of Teladoc Health: AM Healthcare Management Consulting Sdn. Bhd., AMHMS - Health Care Management Services S.A., Advance Holdco Limited, Advance Medical, Advance Medical - Serviços de Consultoria e Gestão de Dados Ltda, Advance Medical Health Care Management Services Chile S.A., Advance Medical Hungary Tanácsadó és Szolgáltató Korlátolt Felelösségü Társaság, Advance Medical Inc., AmeriDoc, Best Doctors, Best Doctors Australasia Pty Limited, Best Doctors Holdings Inc., Best Doctors Inc., Best Doctors International Insurance S.a.r.l., Best Doctors Portugal Ltd., BetterHelp, CogCubed, Compile Inc., Consult A Doctor, HY Holdings Inc., Healthiest You, Institute of Patient Safety and Quality in Virtual Care LLC, Intouch Health, Livongo, MedecinDirect, Médecin Direct, Rise Health Inc., Stat Doctors, Stat Health LLC, TELADOC HEALTH INTERNATIONAL SOCIEDAD ANÓNIMA, TelaDietitian, Teladoc Health Canada Inc., Teladoc Health Massachusetts Holdings Inc., Teladoc Health UK Ltd., and Yi Yi Medical Health Management Consulting (Shanghai) Co. Ltd..
Read More
This page (NYSE:TDOC) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners